Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Cardiovascular Health Improvements: The reduction in visceral adipose tissue and improvements in lipid profiles observed with 5-amino-1MQ treatment suggest potential cardiovascular benefits
30 days (reconstituted) Mechanism Classification Primary Mechanism: NNMT (Nicotinamide N-methyltransferase) Inhibitor Target Enzyme: Nicotinamide N-methyltransferase Cellular Effect: Increases intracellular NAD+ and SAM levels Metabolic Pathway: NAD+ salvage pathway modulation Selectivity: Highly selective for NNMT (no cross-reactivity with related enzymes) Pharmacological Properties Route of Administration: Subcutaneous injection Bioavailability: High (subcutaneous)
Research Context for AHK-CU Peptide Work involving AHK-CU Peptide typically focuses on in vitro systems , assay development, and mechanistic model studies
The compound does not directly affect sex hormones, making it different from some other metabolic interventions
US$ 22.58
US$ 27.76
US$ 24.65
US$ 26.04
US$ 29.94
US$ 25.06
US$ 29.07
US$ 20.85
US$ 29.55
US$ 27.97
US$ 26.39
